GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » EPS (Diluted)

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) EPS (Diluted) : $-0.02 (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings EPS (Diluted)?

Zhong Yuan Bio-Technology Holdings's Earnings per Share (Diluted) for the six months ended in Sep. 2023 was $0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

Zhong Yuan Bio-Technology Holdings's EPS (Basic) for the six months ended in Sep. 2023 was $0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

Zhong Yuan Bio-Technology Holdings's EPS without NRI for the six months ended in Sep. 2023 was $0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was -141.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Zhong Yuan Bio-Technology Holdings's highest 3-Year average EPS without NRI Growth Rate was 12.60% per year. The lowest was -141.00% per year. And the median was -35.70% per year.


Zhong Yuan Bio-Technology Holdings EPS (Diluted) Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings EPS (Diluted) Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
Get a 7-Day Free Trial 0.02 -0.01 - -0.07 -0.13

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.05 -0.08 -0.05 0.03

Competitive Comparison of Zhong Yuan Bio-Technology Holdings's EPS (Diluted)

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhong Yuan Bio-Technology Holdings's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's PE Ratio falls into.



Zhong Yuan Bio-Technology Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Zhong Yuan Bio-Technology Holdings's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.231-0)/17.666
=-0.13

Zhong Yuan Bio-Technology Holdings's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.449-0)/17.686
=0.03

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhong Yuan Bio-Technology Holdings  (OTCPK:ZHYBF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zhong Yuan Bio-Technology Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
Executives
Tingting Chang director, 10 percent owner, officer: CEO RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy director, 10 percent owner, officer: president,secretary,treasurer 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: Vice President 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines